On February 2, 2026, PacBio, a leading developer of high-quality, highly accurate sequencing solutions, announced the completion of the sale of select intellectual property and other assets related to PacBio’s short-read DNA sequencing technology and related clustering, sequencing reagent, and detection technologies to Illumina, Inc. PacBio received approximately $50 million in cash proceeds from the transaction. Wilson Sonsini Goodrich & Rosati advised PacBio on the transaction.

The Wilson Sonsini team that advised PacBio on the transaction included:

Corporate 
Andy Hoffman
Zach Myers
Annie Giomi

M&A
Doug Schnell
Broderick Henry
Joy-Annette Atsegbua
 
Technology Transactions
Ian Edvalson
Shefali Tandon Lumb

For more information, please see PacBio’s news release. Additional coverage can be found on Investing.com and GuruFocus.